Company / SG&A per Share
Oncology Institute, Inc. SG&A per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.42
FY2025
5-year range
$0.57 / $1.63
FY2021-FY2025
Trend
-7.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $1.63 to $1.42 over the past 2 years.
Based on SEC 10-K filings.
1.42 in FY2025 with a 3-year CAGR of +7.7%.
Improved from $1.63 to $1.42 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +7.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share decreased 7.3% year-over-year.
- Peak sg&a per share was recorded in FY2023.
- Lowest sg&a per share in the period was in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.42 | -7.3% |
| FY2024 | $1.54 | -6.0% |
| FY2023 | $1.63 | +43.5% |
| FY2022 | $1.14 | +99.0% |
| FY2021 | $0.57 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026